0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Covid-19 Impact on Congestive Heart Failure (CHF) Treatment Devices Market, Global Research Reports 2020-2021
Published Date: May 2020
|
Report Code: QYRE-Auto-1R3006
Home | Market Reports | Health | Health Conditions | Heart & Hypertension
Covid 19 Impact on Congestive Heart Failure CHF Treatment Devices Market Global Research Reports 2020 2021

Covid-19 Impact on Congestive Heart Failure (CHF) Treatment Devices Market, Global Research Reports 2020-2021

Code: QYRE-Auto-1R3006
Report
May 2020
Pages:98
QYResearch
Description
Table of Content
Tables & Figures
This report covers market size and forecasts of Congestive Heart Failure (CHF) Treatment Devices, including the following market information:
    Global Congestive Heart Failure (CHF) Treatment Devices Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
    Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
    Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
    Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)
Key market players
Major competitors identified in this market include Abiomed, Berlin Heart GmbH, Biotronik SE & Co. KG, Boston Scientific Corporation, HeartWare International, Jarvik Heart, LivaNova PLC, Medtronic, ReliantHeart, Abbott, etc.
Based on the Region:
    Asia-Pacific (China, Japan, South Korea, India and ASEAN)
    North America (US and Canada)
    Europe (Germany, France, UK and Italy)
    Rest of World (Latin America, Middle East & Africa)
Based on the Type:
    Cardiac Resynchronization Therapy (CRT)
    Implantable Cardioverter Defibrillators (ICDs)
Based on the Application:
    Left Ventricular Assist Device (LVAD)
    Right Ventricular Assist Device (RVAD)
    Biventricular Assist Device (BIVAD)
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Congestive Heart Failure (CHF) Treatment Devices Industry
1.7 COVID-19 Impact: Congestive Heart Failure (CHF) Treatment Devices Market Trends
2 Global Congestive Heart Failure (CHF) Treatment Devices Quarterly Market Size Analysis
2.1 Congestive Heart Failure (CHF) Treatment Devices Business Impact Assessment - COVID-19
2.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Congestive Heart Failure (CHF) Treatment Devices Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 Global Congestive Heart Failure (CHF) Treatment Devices Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Congestive Heart Failure (CHF) Treatment Devices Factory Price by Manufacturers
3.3 Location of Key Manufacturers Congestive Heart Failure (CHF) Treatment Devices Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Congestive Heart Failure (CHF) Treatment Devices Market
3.5 Key Manufacturers Congestive Heart Failure (CHF) Treatment Devices Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Congestive Heart Failure (CHF) Treatment Devices Segments, By Type
4.1 Introduction
1.4.1 Cardiac Resynchronization Therapy (CRT)
1.4.2 Implantable Cardioverter Defibrillators (ICDs)
4.2 By Type, Global Congestive Heart Failure (CHF) Treatment Devices Market Size, 2019-2021
4.2.1 By Type, Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Type, 2020-2021
4.2.2 By Type, Global Congestive Heart Failure (CHF) Treatment Devices Price, 2020-2021
5 Impact of Covid-19 on Congestive Heart Failure (CHF) Treatment Devices Segments, By Application
5.1 Overview
5.5.1 Left Ventricular Assist Device (LVAD)
5.5.2 Right Ventricular Assist Device (RVAD)
5.5.3 Biventricular Assist Device (BIVAD)
5.2 By Application, Global Congestive Heart Failure (CHF) Treatment Devices Market Size, 2019-2021
5.2.1 By Application, Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Application, 2019-2021
5.2.2 By Application, Global Congestive Heart Failure (CHF) Treatment Devices Price, 2020-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Abiomed
7.1.1 Abiomed Business Overview
7.1.2 Abiomed Congestive Heart Failure (CHF) Treatment Devices Quarterly Production and Revenue, 2020
7.1.3 Abiomed Congestive Heart Failure (CHF) Treatment Devices Product Introduction
7.1.4 Abiomed Response to COVID-19 and Related Developments
7.2 Berlin Heart GmbH
7.2.1 Berlin Heart GmbH Business Overview
7.2.2 Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Quarterly Production and Revenue, 2020
7.2.3 Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Product Introduction
7.2.4 Berlin Heart GmbH Response to COVID-19 and Related Developments
7.3 Biotronik SE & Co. KG
7.3.1 Biotronik SE & Co. KG Business Overview
7.3.2 Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Quarterly Production and Revenue, 2020
7.3.3 Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Product Introduction
7.3.4 Biotronik SE & Co. KG Response to COVID-19 and Related Developments
7.4 Boston Scientific Corporation
7.4.1 Boston Scientific Corporation Business Overview
7.4.2 Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Quarterly Production and Revenue, 2020
7.4.3 Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Product Introduction
7.4.4 Boston Scientific Corporation Response to COVID-19 and Related Developments
7.5 HeartWare International
7.5.1 HeartWare International Business Overview
7.5.2 HeartWare International Congestive Heart Failure (CHF) Treatment Devices Quarterly Production and Revenue, 2020
7.5.3 HeartWare International Congestive Heart Failure (CHF) Treatment Devices Product Introduction
7.5.4 HeartWare International Response to COVID-19 and Related Developments
7.6 Jarvik Heart
7.6.1 Jarvik Heart Business Overview
7.6.2 Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Quarterly Production and Revenue, 2020
7.6.3 Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Product Introduction
7.6.4 Jarvik Heart Response to COVID-19 and Related Developments
7.7 LivaNova PLC
7.7.1 LivaNova PLC Business Overview
7.7.2 LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Quarterly Production and Revenue, 2020
7.7.3 LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Product Introduction
7.7.4 LivaNova PLC Response to COVID-19 and Related Developments
7.8 Medtronic
7.8.1 Medtronic Business Overview
7.8.2 Medtronic Congestive Heart Failure (CHF) Treatment Devices Quarterly Production and Revenue, 2020
7.8.3 Medtronic Congestive Heart Failure (CHF) Treatment Devices Product Introduction
7.8.4 Medtronic Response to COVID-19 and Related Developments
7.9 ReliantHeart
7.9.1 ReliantHeart Business Overview
7.9.2 ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Quarterly Production and Revenue, 2020
7.9.3 ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Product Introduction
7.9.4 ReliantHeart Response to COVID-19 and Related Developments
7.10 Abbott
7.10.1 Abbott Business Overview
7.10.2 Abbott Congestive Heart Failure (CHF) Treatment Devices Quarterly Production and Revenue, 2020
7.10.3 Abbott Congestive Heart Failure (CHF) Treatment Devices Product Introduction
7.10.4 Abbott Response to COVID-19 and Related Developments
8 Supply Chain and Sales Channels Analysis
8.1 Congestive Heart Failure (CHF) Treatment Devices Supply Chain Analysis
8.1.1 Congestive Heart Failure (CHF) Treatment Devices Supply Chain Analysis
8.1.2 Covid-19 Impact on Congestive Heart Failure (CHF) Treatment Devices Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Congestive Heart Failure (CHF) Treatment Devices Distribution Channels
8.2.2 Covid-19 Impact on Congestive Heart Failure (CHF) Treatment Devices Distribution Channels
8.2.3 Congestive Heart Failure (CHF) Treatment Devices Distributors
8.3 Congestive Heart Failure (CHF) Treatment Devices Customers
9 Key Findings
10 Appendix
10.1 About Us
10.2 Disclaimer
List of Tables
    Table 1. Overview of the World Economic Outlook Projections
    Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
    Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
    Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
    Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
    Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
    Table 7. Covid-19 Impact: Global Major Government Policy
    Table 8. The Covid-19 Impact on Congestive Heart Failure (CHF) Treatment Devices Assessment
    Table 9. COVID-19 Impact: Congestive Heart Failure (CHF) Treatment Devices Market Trends
    Table 10. COVID-19 Impact Global Congestive Heart Failure (CHF) Treatment Devices Market Size
    Table 11. Global Congestive Heart Failure (CHF) Treatment Devices Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)
    Table 12. Global Congestive Heart Failure (CHF) Treatment Devices Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)
    Table 13. Global Congestive Heart Failure (CHF) Treatment Devices Quarterly Market Size, 2020 (US$ Million) & (K Units)
    Table 14. Global Congestive Heart Failure (CHF) Treatment Devices Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
    Table 15. Global Congestive Heart Failure (CHF) Treatment Devices Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)
    Table 16. Global Congestive Heart Failure (CHF) Treatment Devices Market Growth Drivers
    Table 17. Global Congestive Heart Failure (CHF) Treatment Devices Market Restraints
    Table 18. Global Congestive Heart Failure (CHF) Treatment Devices Market Opportunities
    Table 19. Global Congestive Heart Failure (CHF) Treatment Devices Market Challenges
    Table 20. Key Manufacturers Congestive Heart Failure (CHF) Treatment Devices Quarterly Revenue, 2019 VS 2020 (US$ Million)
    Table 21. Top Manufacturers, Congestive Heart Failure (CHF) Treatment Devices Market Size, 2019 (K Units) & (US$ Million)
    Table 22. Congestive Heart Failure (CHF) Treatment Devices Factory Price by Manufacturers 2020 (USD/Unit)
    Table 23. Location of Key Manufacturers Congestive Heart Failure (CHF) Treatment Devices Manufacturing Plants
    Table 24. Key Manufacturers Congestive Heart Failure (CHF) Treatment Devices Market Served
    Table 25. Date of Key Manufacturers Enter into Congestive Heart Failure (CHF) Treatment Devices Market
    Table 26. Key Manufacturers Congestive Heart Failure (CHF) Treatment Devices Product Type
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Type, 2020, (US$ Million)
    Table 29. Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Type, 2020 (K Units)
    Table 30. Global Congestive Heart Failure (CHF) Treatment Devices Price: by Type, 2020-2021 (USD/Unit)
    Table 31. Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Application: 2020-2021 (US$ Million)
    Table 32. Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Application, 2020-2021 (K Units)
    Table 33. Global Congestive Heart Failure (CHF) Treatment Devices Price: by Application, 2020-2021 (USD/Unit)
    Table 34. Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Region, 2019-2021 (US$ Million)
    Table 35. Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Region, 2019-2021 (K Units)
    Table 36. By Country, North America Congestive Heart Failure (CHF) Treatment Devices Market Size, 2019-2021 (US$ Million)
    Table 37. By Country, North America Congestive Heart Failure (CHF) Treatment Devices Market Size, 2019-2021 (K Units)
    Table 38. US Congestive Heart Failure (CHF) Treatment Devices Market Size, 2019-2021 (US$ Million) & (K Units)
    Table 39. Canada Congestive Heart Failure (CHF) Treatment Devices Market Size, 2019-2021 (US$ Million) & (K Units)
    Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
    Table 41. By Country, Europe Congestive Heart Failure (CHF) Treatment Devices Market Size, 2019-2021 (US$ Million)
    Table 42. By Country, Europe Congestive Heart Failure (CHF) Treatment Devices Market Size, 2019-2021 (K Units)
    Table 43. Germany Congestive Heart Failure (CHF) Treatment Devices Market Size, 2019-2021 (US$ Million) & (K Units)
    Table 44. France Congestive Heart Failure (CHF) Treatment Devices Market Size, 2019-2021 (US$ Million) & (K Units)
    Table 45. UK Congestive Heart Failure (CHF) Treatment Devices Market Size, 2019-2021 (US$ Million) & (K Units)
    Table 46. Italy Congestive Heart Failure (CHF) Treatment Devices Market Size, 2019-2021 (US$ Million) & (K Units)
    Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
    Table 48. By Region, Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Market Size, 2019-2021 (US$ Million)
    Table 49. By Region, Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Market Size, 2019-2021 (K Units)
    Table 50. China Congestive Heart Failure (CHF) Treatment Devices Market Size, 2019-2021 (US$ Million) & (K Units)
    Table 51. Japan Congestive Heart Failure (CHF) Treatment Devices Market Size, 2019-2021 (US$ Million) & (K Units)
    Table 52. South Korea Congestive Heart Failure (CHF) Treatment Devices Market Size, 2019-2021 (US$ Million) & (K Units)
    Table 53. India Congestive Heart Failure (CHF) Treatment Devices Market Size, 2019-2021 (US$ Million) & (K Units)
    Table 54. ASEAN Congestive Heart Failure (CHF) Treatment Devices Market Size, 2019-2021 (US$ Million) & (K Units)
    Table 55. Latin America Congestive Heart Failure (CHF) Treatment Devices Market Size, 2019-2021 (US$ Million) & (K Units)
    Table 56. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Market Size, 2019-2021 (US$ Million) & (K Units)
    Table 57. Abiomed Business Overview
    Table 58. Abiomed Congestive Heart Failure (CHF) Treatment Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
    Table 59. Abiomed Congestive Heart Failure (CHF) Treatment Devices Product
    Table 60. Abiomed Response to COVID-19 and Related Developments
    Table 61. Berlin Heart GmbH Business Overview
    Table 62. Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
    Table 63. Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Product
    Table 64. Berlin Heart GmbH Response to COVID-19 and Related Developments
    Table 65. Biotronik SE & Co. KG Business Overview
    Table 66. Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
    Table 67. Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Product
    Table 68. Biotronik SE & Co. KG Response to COVID-19 and Related Developments
    Table 69. Boston Scientific Corporation Business Overview
    Table 70. Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
    Table 71. Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Product
    Table 72. Boston Scientific Corporation Response to COVID-19 and Related Developments
    Table 73. HeartWare International Business Overview
    Table 74. HeartWare International Congestive Heart Failure (CHF) Treatment Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
    Table 75. HeartWare International Congestive Heart Failure (CHF) Treatment Devices Product
    Table 76. HeartWare International Response to COVID-19 and Related Developments
    Table 77. Jarvik Heart Business Overview
    Table 78. Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
    Table 79. Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Product
    Table 80. Jarvik Heart Response to COVID-19 and Related Developments
    Table 81. LivaNova PLC Business Overview
    Table 82. LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
    Table 83. LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Product
    Table 84. LivaNova PLC Response to COVID-19 and Related Developments
    Table 85. Medtronic Business Overview
    Table 86. Medtronic Congestive Heart Failure (CHF) Treatment Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
    Table 87. Medtronic Congestive Heart Failure (CHF) Treatment Devices Product
    Table 88. Medtronic Response to COVID-19 and Related Developments
    Table 89. ReliantHeart Business Overview
    Table 90. ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
    Table 91. ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Product
    Table 92. ReliantHeart Response to COVID-19 and Related Developments
    Table 93. Abbott Business Overview
    Table 94. Abbott Congestive Heart Failure (CHF) Treatment Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
    Table 95. Abbott Congestive Heart Failure (CHF) Treatment Devices Product
    Table 96. Abbott Response to COVID-19 and Related Developments
    Table 97. Congestive Heart Failure (CHF) Treatment Devices Distributors List
    Table 98. Congestive Heart Failure (CHF) Treatment Devices Customers List
    Table 99. Covid-19 Impact on Congestive Heart Failure (CHF) Treatment Devices Customers
List of Figures
    Figure 1. Congestive Heart Failure (CHF) Treatment Devices Product Picture
    Figure 2. Congestive Heart Failure (CHF) Treatment Devices Market Segmentation
    Figure 3. Research Objectives
    Figure 4. Research Process
    Figure 5. Data Triangulation
    Figure 6. Research Approach
    Figure 7. Commodity Prices-Metals Price Indices
    Figure 8. Commodity Prices- Precious Metal Price Indices
    Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
    Figure 10. Commodity Prices- Food and Beverage Price Indices
    Figure 11. Commodity Prices- Fertilizer Price Indices
    Figure 12. Commodity Prices- Energy Price Indices
    Figure 13. G20+: Economic Policy Responses to COVID-19
    Figure 14. Global Congestive Heart Failure (CHF) Treatment Devices Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
    Figure 15. Global Congestive Heart Failure (CHF) Treatment Devices Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
    Figure 16. Global Congestive Heart Failure (CHF) Treatment Devices Market Size, Quarterly Growth, 2020-2021 (%)
    Figure 17. Global Congestive Heart Failure (CHF) Treatment Devices Market Size, Market Share by Type, 2019 VS 2020 (%)
    Figure 18. Global Congestive Heart Failure (CHF) Treatment Devices Market Size, Market Share by Application, 2019 VS 2020 (%)
    Figure 19. Global Congestive Heart Failure (CHF) Treatment Devices Market Size Market Share by Region, 2019 VS 2020 (%)
    Figure 20. United States Composite PMI and GDP
    Figure 21. Eurozone Composite PMI and GDP
    Figure 22. Eurozone Core v. Periphery PMI Output Indices
    Figure 23. Core v. Periphery PMI Employment Indices
    Figure 24. UK Composite PMI and GDP
    Figure 25. Caixin China Composite Output Index
    Figure 26. Caixin China General Services Business Activity Index
    Figure 27. Japan Composite Output Index
    Figure 28. South Korea Manufacturing PMI
    Figure 29. India Composite Output Index
    Figure 30. ASEAN Manufacturing PMI
    Figure 31. By Region, Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Market Size Market Share, 2019-2021
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3250

This license allows only one user(purchaser of the report) to access the PDF.
Electronic (PDF)

$4875

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$6500

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Seventh Sense AI
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Coronary Artery Imaging Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-37R6046
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global ECG Devices Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-23S9116
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Decentralized & POC Coagulation Testing Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-7S6333
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Transcatheter Aortic Valve Implantation (TAVI) System Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-37M13084
Sun Apr 07 00:00:00 UTC 2024

Add to Cart